SGMT
Sagimet BiosciencesDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
SGMT vs peer average
43/100
SGMT vs. peer average (D vs. D)
Grade spread
A 1 · B 1 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
PRME is the first available peer comparator.
Similar small-cap clinical-development and financing risk, but gene editing is not a direct acne or FASN comparison; unsuitable for a precise valuation multiple.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SGMT
Sagimet Biosciences
PRME
Prime Medicine
Grade
D
D
Momentum
63
95
Value
41
41
Sentiment
40
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs PRME
SGMT / PRME
Grade Position
Below peers
SGMT vs. peer average (D vs. D)
43/100
Momentum
63
PRMEValue
41
SGMTSentiment
40
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SGMT
PRME is the first peer returned for this comparison set.